A Phase 2 Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host Disease
Phase of Trial: Phase II
Latest Information Update: 22 Nov 2017
At a glance
- Drugs Rituximab (Primary) ; Ciclosporin; Prednisone; Tacrolimus
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 19 Oct 2017 Status changed from active, no longer recruiting to completed.
- 17 Dec 2013 Planned End Date changed from 1 May 2012 to 1 Jun 2014 as reported by ClinicalTrials.gov record.
- 11 Jul 2012 Planned end date changed from 1 Jun 2012 to 1 May 2012 as reported by ClinicalTrials.gov.